Moderna (MRNA) Net Margin (2017 - 2026)
Moderna (MRNA) posted quarterly Net Margin of 539.31% for Q2 2026, up 4168.0% year-over-year from 12.64% in Q2 2025, and down 56.21% on a QoQ basis from 345.24% in Q1 2026.
Moderna (MRNA) Net Margin (2017 - 2026) Analysis & Trends
Moderna has reported Net Margin for 10 years, with the latest figure at 539.31% in Q2 2026.
- Net Margin for Q2 2026 came in at 539.31%, up 4168.0% year-over-year; the trailing twelve-month figure through Jun 2026 was 141.43% (down 4711.0% YoY), and the FY2025 annual result was 145.16%, down 3512.0% from the prior year.
- Net Margin declined to 539.31% in Q2 2026, from 345.24% in the prior quarter.
- Over five years, Net Margin peaked at 60.29% in Q1 2022 and troughed at 899.07% in Q1 2025.
- A 5-year average of 237.6% and a median of 118.89% in 2024 frame the typical range for Net Margin.
- The widest annual swing landed in 2024, when Net Margin sank 70784 bps; it then surged 55383 bps in 2026.
- A 5-year view of Net Margin shows it stood at 28.82% in 2022, then plunged by 73 bps to 7.72% in 2023, then plunged by 1602 bps to 115.94% in 2024, then dropped by 5 bps to 121.83% in 2025, then sank by 343 bps to 539.31% in 2026.
- Per Business Quant data, the three most recent Net Margin figures were 539.31% in Q2 2026, 345.24% in Q1 2026, and 121.83% in Q4 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 137.11 Bn | 129.26 Bn | 2.84 Bn | 32.99% |
| 2 | Regeneron Pharmaceuticals | 84.98 Bn | 76.99 Bn | 3.93 Bn | 30.23% |
| 3 | Argenx Se | 64.52 Bn | 59.33 Bn | 1.37 Bn | 31.16% |
| 4 | Moderna | 53.23 Bn | 48.09 Bn | 52.00 Mn | -539.31% |
| 5 | BeOne Medicines | 41.23 Bn | 36.14 Bn | 1.53 Bn | 13.90% |
| 6 | Alnylam Pharmaceuticals | 30.65 Bn | 27.34 Bn | 992.69 Mn | 12.74% |
| 7 | Insmed | 27.15 Bn | 25.99 Bn | 358.27 Mn | -3.12% |
| 8 | Royalty Pharma | 26.98 Bn | 26.14 Bn | - | 12.09% |
| 9 | BioNTech SE | 26.78 Bn | 8.39 Bn | 668.28 Mn | -16.51% |
| 10 | Roivant Sciences | 26.52 Bn | 26.52 Bn | 1.16 Mn | -20,152.98% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | -539.31% |
| Mar 31, 2026 | -345.24% |
| Dec 31, 2025 | -121.83% |
| Sep 30, 2025 | -19.69% |
| Jun 30, 2025 | -580.99% |
| Mar 31, 2025 | -899.07% |
| Dec 31, 2024 | -115.94% |
| Sep 30, 2024 | 0.70% |
| Jun 30, 2024 | -530.71% |
| Mar 31, 2024 | -703.59% |
| Dec 31, 2023 | 7.72% |
| Sep 30, 2023 | -198.25% |
| Jun 30, 2023 | -401.16% |
| Mar 31, 2023 | 4.24% |
| Dec 31, 2022 | 28.82% |
| Sep 30, 2022 | 31.00% |
| Jun 30, 2022 | 46.26% |
| Mar 31, 2022 | 60.29% |
| Dec 31, 2021 | 67.51% |
| Sep 30, 2021 | 67.08% |